MedTrace Logo

Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia

NCT03024021 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-03-10

No results posted yet for this study

Summary

This study is designed to assess the effect of cerebral oxygen saturation as an early predictor of neurological outcomes in patients undergoing therapeutic hypothermia after cardiac arrest

Conditions

  • Hypoxic-Ischemic Encephalopathy
  • Post-Cardiorespiratory Arrest Coma
  • Cardiac Arrest

Interventions

DEVICE

Near-infrared spectroscopy (NIRS) (INVOS®, Covidien)

As we start the targeted temperature management protocol (24 hours of hypothermia adjusted to 33-36 C and afterwards up to five days of normothermia \[36.5 C\]) NIRS sensor pads will be placed over the right and left frontal area. Regional cerebral oxygen values will be continuously recorded at the NIRS monitor. Tests to assess neurological outcome will be performed. Patients will be assessed in terms of neurological performance tests and regional cerebral oxygen.

Sponsors & Collaborators

  • Tepecik Training and Research Hospital

    lead OTHER

Principal Investigators

  • Aykut Saritas · Tepecik Research and Training Hospital

  • Burcu Acar Cinleti · suat seren research and training hospital

  • Ciler Zincircioglu · Tepecik Research and Training Hospital

  • İsil Kose · Tepecik Research and Training Hospital

  • Ugur Uzun · Tepecik Research and Training Hospital

  • Nimet Senoglu · Tepecik Research and Training Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-09-30
Completion
2018-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024021 on ClinicalTrials.gov